Illinois Municipal Retirement Fund Trims Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Illinois Municipal Retirement Fund lessened its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 70.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 26,299 shares of the medical instruments supplier’s stock after selling 63,507 shares during the period. Illinois Municipal Retirement Fund’s holdings in DENTSPLY SIRONA were worth $936,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Bar Harbor Wealth Management bought a new stake in DENTSPLY SIRONA during the fourth quarter valued at about $4,931,000. DAVENPORT & Co LLC bought a new stake in DENTSPLY SIRONA during the fourth quarter valued at about $1,220,000. Andra AP fonden boosted its stake in shares of DENTSPLY SIRONA by 20.3% in the third quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier’s stock worth $10,340,000 after acquiring an additional 51,100 shares during the period. Envestnet Asset Management Inc. boosted its stake in shares of DENTSPLY SIRONA by 98.1% in the third quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier’s stock worth $11,861,000 after acquiring an additional 171,958 shares during the period. Finally, Mirabella Financial Services LLP bought a new position in shares of DENTSPLY SIRONA in the third quarter worth about $802,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $30.57 on Monday. The stock has a market cap of $6.34 billion, a price-to-earnings ratio of -49.31, a price-to-earnings-growth ratio of 1.24 and a beta of 0.98. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38. The stock has a 50 day moving average price of $32.53 and a 200-day moving average price of $32.78. DENTSPLY SIRONA Inc. has a one year low of $26.27 and a one year high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $972.61 million. During the same period last year, the company earned $0.46 EPS. DENTSPLY SIRONA’s quarterly revenue was up 3.0% compared to the same quarter last year. Equities analysts expect that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were paid a dividend of $0.16 per share. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -103.22%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Barrington Research reaffirmed an “outperform” rating and issued a $41.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Finally, Piper Sandler raised their price target on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Friday, January 12th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $39.50.

Check Out Our Latest Report on XRAY

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.